Ribozymes: an anti-viral agent

被引：0
作者：
Khan, Asad U. [1 ]
Khan, Shahper N. [1 ]
机构：
[1] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh 202002, Uttar Pradesh, India
来源：
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE | 2008年 / 1卷 / 02期
关键词：
ribozyme; molecular tool; gene therapy;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：76 / 82
页数：7
相关论文
共 38 条
  • [21] Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4+ T cells in vitro
    C Klebba
    O G Ottmann
    M Scherr
    M Pape
    J W Engels
    M Grez
    D Hoelzer
    S A Klein
    Gene Therapy, 2000, 7 : 408 - 416
  • [22] Prospects for Foamy Viral Vector Anti-HIV Gene Therapy
    Nalla, Arun K.
    Trobridge, Grant D.
    BIOMEDICINES, 2016, 4 (02)
  • [23] Viral-Vector-Delivered Anti-Angiogenic Therapies to the Eye
    Koponen, Sanna
    Kokki, Emmi
    Kinnunen, Kati
    Yla-Herttuala, Seppo
    PHARMACEUTICS, 2021, 13 (02) : 1 - 22
  • [24] Protection of platinum-DNA adduct formation and reversal of cisplatin resistance by anti-MRP2 hammerhead ribozymes in human cancer cells
    Materna, V
    Liedert, B
    Thomale, J
    Lage, H
    INTERNATIONAL JOURNAL OF CANCER, 2005, 115 (03) : 393 - 402
  • [25] Using a commercial ultrasound contrast agent for viral-mediated gene transfer in vitro and in vivo
    Howard, Candace M.
    Forsberg, Flemming
    Liu, Ji-Bin
    Merton, Daniel A.
    Minimo, Corrado
    Claudio, Pier P.
    6TH INTERNATIONAL SYMPOSIUM ON THERAPEUTIC ULTRASOUND, 2007, 911 : 526 - 532
  • [26] Analysis of the Potential for HIV-1 Vpr as an Anti-Cancer Agent
    Muthumani, Karrupiah
    Lambert, Vance M.
    Sardesai, Niranjan Y.
    Kim, Jong J.
    Heller, Richard
    Weiner, David B.
    Ugen, Kenneth E.
    CURRENT HIV RESEARCH, 2009, 7 (02) : 144 - 152
  • [27] Effect of deletion and the site of insertion in double copy anti-tat retroviral vectors: viral titres and production of anti-tat mRNA
    J. M. Carr
    J. K. Calvert
    R. Kumar
    C. J. Burrell
    P. Li
    Archives of Virology, 2001, 146 : 2191 - 2200
  • [28] Genetically Engineered Mesenchymal Stem Cells using Viral Vectors: ANew Frontier in Anti-Angiogenic Therapy
    Wa, Ewa choy yee
    Woon, Choy ker
    Siong, Woon kai
    Wafi, Muhammad aidil
    Yong, Then kong
    Lek, Then khong
    SAINS MALAYSIANA, 2024, 53 (01): : 63 - 86
  • [29] Higher Seroprevalence of Anti-Adeno-Associated Viral Vector Neutralizing Antibodies Among Racial Minorities in the United States
    Khatri, Arpana
    Shelke, Rajani
    Guan, Shunjie
    Somanathan, Suryanarayan
    HUMAN GENE THERAPY, 2022, 33 (7-8) : 442 - 450
  • [30] Determination of Anti-Adeno-Associated Viral Vector Neutralizing Antibodies in Patients With Heart Failure in the Cardiovascular Foundation of Colombia (ANVIAS): Study Protocol
    Rincon, Melvin Y.
    Prada, Carlos E.
    Lopez, Marcos
    Castillo, Victor
    Eduardo Echeverria, Luis
    Serrano, Norma
    JMIR RESEARCH PROTOCOLS, 2016, 5 (02):
1234